Abbott Laboratories vs Danaher
Abbott Laboratories (ABT), health care, and Danaher (DHR), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.
Abbott Laboratories is worth $184.1B on the stock market and Danaher $159.2B: Abbott Laboratories is valued at 16% more. Abbott Laboratories trades at 39.7 times earnings and Danaher at 37.5; operating margins in their latest fiscal years were 18.2% and 19.1%. Over the past year Abbott Laboratories's share price has moved -17.3% and Danaher's +1.95%.
Key facts
- Abbott Laboratories market value
- $184.1B
- Danaher market value
- $159.2B
- Abbott Laboratories P/E
- 39.7
- Danaher P/E
- 37.5
- Abbott Laboratories revenue
- $44.3BFY to 2025-12-31
- Danaher revenue
- $24.6BFY to 2025-12-31
- Superinvestors holding both
- 2
Market values as of .
| Measure | Abbott Laboratories | Danaher |
|---|---|---|
| Sector | Health Care | Health Care |
| Country | ||
| Fiscal year ends | 2025-12-31 | 2025-12-31 |
| Size | ||
| Market cap | $184.1Bhigher | $159.2Blower |
| Revenue | $44.3Bhigher | $24.6Blower |
| Earnings | $6.5Bhigher | $3.6Blower |
| Employees | 122,000higher | 58,000lower |
| Total assets | $86.7Bhigher | $83.5Blower |
| Valuation | ||
| P/E | 39.7higher | 37.5lower |
| P/S | 4.2lower | 6.5higher |
| P/B | 3.6higher | 3.0lower |
| Dividend yield | 2.35%higher | 0.66%lower |
| Profitability | ||
| Operating margin | 18.2%lower | 19.1%higher |
| Balance sheet | ||
| Net assets | $52.1Blower | $52.5Bhigher |
| Total liabilities | $33.9Bhigher | $30.9Blower |
| Total debt | $12.9Blower | $18.4Bhigher |
| Cash on hand | $8.5Bhigher | $4.6Blower |
| Price change | ||
| Today | -1.09%higher | -1.57%lower |
| 1 year | -17.3%lower | +1.95%higher |
Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.
Which superinvestors hold them
From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.
Both (2)
- Brandon Haley0.5% / 1.6%
- Israel Englander0.2% / 0.3%
Abbott Laboratories only (13)
- Mason Hawkins4.0%
- Jensen team2.4%
- Diamond Hill team2.2%
- Jeremy Grantham (co-founder)1.9%
- Mairs & Power team0.7%
- Ken Griffin0.4%
- John Overdeck and David Siegel (founders)0.4%
- Paul Tudor Jones0.3%
- Steve Cohen0.2%
- Lew Sanders0.1%
- George Soros0.1%
- Thomas Russo<0.1%
- Howard Gleicher<0.1%
Danaher only (17)
- Wallace Weitz7.0%
- Eric Bannasch4.8%
- Larry Robbins4.4%
- Doug Silverman2.3%
- Dan Loeb2.2%
- Daniel Sundheim2.1%
- Steven Romick1.5%
- Dodge & Cox team1.2%
- Chase Coleman0.4%
- Ken Fisher0.3%
- Primecap team0.3%
- Louis Bacon0.2%
- Stanley Druckenmiller0.2%
- Bill Gates0.2%
- Cliff Asness0.2%
- Rajiv Jain<0.1%
- Bill Nygren<0.1%
Percentages are each holding's share of that investor's reported portfolio (under "Both": Abbott Laboratories / Danaher). Who owns ABT · Who owns DHR
More on Abbott Laboratories
Further comparisons
Abbott Laboratories against its closest peers
Danaher against its closest peers
Learn
Questions and answers
Which is bigger, Abbott Laboratories or Danaher?
By market value, Abbott Laboratories is the larger: $184.1B against $159.2B for Danaher. By revenue in its latest fiscal year, Abbott Laboratories is the larger: $44.3B against $24.6B for Danaher.
Which has the higher P/E ratio?
Abbott Laboratories: 39.7, against 37.5 for Danaher. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.
Which has the higher operating margin?
Danaher: 19.1%, against 18.2% for Abbott Laboratories. Operating margin is operating income as a share of revenue in the latest fiscal year.
Which has the higher dividend yield?
Abbott Laboratories: 2.35%, against 0.66% for Danaher. Dividend yield is the last twelve months' dividends as a share of today's share price.
Which has more debt?
Danaher: $18.4B, against $12.9B for Abbott Laboratories. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.
Which superinvestors own both Abbott Laboratories and Danaher?
In their latest 13F filings, Brandon Haley and Israel Englander hold both.
Cite this page
Funkfolio, “Abbott Laboratories vs Danaher”, data as of 17 November 2026. https://funkfolio.com/compare/abt-vs-dhr
Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.